Written Description Requirement under U.S.C. 112, 1st Paragraph- Recent USPTO Guidelines Present Significant Obstacles for Antibody-Based Inventions in the US
By: Patent Attorneys Dr. Hadassa Waterman, Head of the Biotech Department and Dr. David Mencher, of Ehrlich & Fenster of Ehrlich Group Current USPTO guidelines for antibody-based inventions (see “Guidelines”1)...